Provided by Tiger Trade Technology Pte. Ltd.

Twist Bioscience Corp

62.61
+0.73001.18%
Pre-market: 64.501.89+3.02%07:23 EDT
Volume:1.66M
Turnover:105.20M
Market Cap:3.83B
PE:-49.29
High:65.10
Open:63.14
Low:62.12
Close:61.88
52wk High:65.10
52wk Low:23.30
Shares:61.15M
Float Shares:59.26M
Volume Ratio:1.02
T/O Rate:2.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2703
EPS(LYR):-1.2987
ROE:-16.79%
ROA:-13.49%
PB:8.39
PE(LYR):-48.21

Loading ...

Twist Bio CFO Adam Laponis disposes of 4,000 shares worth $240,000

Reuters
·
16 hours ago

Press Release: Twist Bioscience to Report Fiscal 2026 Second Quarter Financial Results on Monday, May 4, 2026

Dow Jones
·
Yesterday

Twist Bioscience CFO Adam Laponis sells 3,000 shares worth $165,000

Reuters
·
Apr 17

Twist Bioscience Is Maintained at Overweight by Barclays

Dow Jones
·
Apr 15

CORRECTED-Amazon launches AI research tool to speed early-stage drug discovery

Reuters
·
Apr 14

Twist Bioscience Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Apr 07

Twist Bioscience Director Melissa Starovasnik sells USD 51 million common shares

Reuters
·
Apr 04

Twist Bioscience Is Maintained at Buy by Guggenheim

Dow Jones
·
Mar 30

Twist Bioscience price target raised to $55 from $50 at Guggenheim

TIPRANKS
·
Mar 30

CORRECTED-UK's Aptamer H1 revenue rises on new pharma contracts

Reuters
·
Mar 25

Is Twist Bioscience (TWST) Using Invenra Deal To Quietly Redefine Its Biologics Platform Strategy?

Simply Wall St.
·
Feb 28

Twist Bioscience Expands Antibody Discovery With Invenra Bispecific Platform Deal

Simply Wall St.
·
Feb 26

Twist Bioscience Stock (TWST) Tumbles after Senior Executive Offloads $2M in Shares

TIPRANKS
·
Feb 21

Twist Bioscience SVP of Human Resources Paula Green Disposes of Common Shares

Reuters
·
Feb 20

Twist Bioscience President and COO Patrick John Finn Disposes of Common Shares

Reuters
·
Feb 20

Twist Bioscience to Join Fireside Chats at TD Cowen, Barclays and Leerink Healthcare Investor Conferences

Reuters
·
Feb 18

Twist Bioscience Licenses Invenra's B-Body Platform to Expand Bispecific Antibody Discovery Services

MT Newswires Live
·
Feb 17

BRIEF-Twist Bioscience Expands Antibody Discovery Offering With Bispecific Licensing Agreement

Reuters
·
Feb 17

Twist Bioscience acquires 6% stake in Invenra with stock purchase

Reuters
·
Feb 17

Twist Bioscience Corp - to Pay Invenra 20% Royalty on License Revenue

THOMSON REUTERS
·
Feb 17